纽约市COVID-19重症患者急性肾损伤发病率下降
该研究基于纽约3家医院2020年3月2日至8月25日收治的4732例COVID-19住院患者,发现29.3%发生急性肾损伤(AKI),且AKI与高死亡率相关(51.6% vs 8.6%)。AKI发病率从3月的32.5%降至8月的17.2%(P<0.001),幸存者中77%肾功能恢复至基线肌酐0.3 mg/dl以内。
要点
- COVID-19住院患者AKI发生率29.3%,需RRT者死亡率达71.9%。
- AKI发病率随时间下降,3月32.5% vs 8月17.2%(P<0.001)。
- AKI幸存者77%肾功能恢复至基线0.3 mg/dl以内,62%停用RRT。
核心结论
- COVID-19住院患者AKI发生率高且与高死亡率相关,尤其需要RRT时。
- AKI发病率在研究期间呈下降趋势,幸存者肾功能常可恢复。
研究设计与样本
- 回顾性队列研究,使用电子病历识别2020年3月2日至8月25日纽约3家医院收治的COVID-19患者,共4732例住院。
主要发现
- 4732例住院中1386例(29.3%)发生AKI;其中1期717例(51.7%),2期132例(9.5%),3期537例(38.7%),237例(17.1%)需要启动RRT。
- 3月AKI发生率为32.5%(536/1648),8月为17.2%(15/87),月度趋势P<0.001;RRT启动率3月为6.9%,8月为0%。
- AKI患者死亡率51.6%,无AKI患者8.6%;需要RRT者死亡率71.9%。
- AKI幸存者中77%恢复至基线肌酐0.3 mg/dl以内;出院幸存者中62%停用RRT。
临床怎么用
- 临床应关注COVID-19住院患者AKI风险,尤其需要RRT者死亡率高。
- 幸存者肾功能常可恢复,但需监测长期肾功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Reports from the United States suggest that acute kidney injury (AKI) frequently complicates coronavirus disease 2019 (COVID-19), but understanding of AKI risks and outcomes is incomplete. In addition, whether kidney outcomes have evolved during the course of the pandemic is unknown. METHODS: We used electronic medical records to identify patients with COVID-19 with and without AKI admitted to 3 New York Hospitals between March 2 and August 25, 2020. Outcomes included AKI overall and according to admission week, AKI stage, the requirement for new renal replacement therapy (RRT), mortality, and recovery of kidney function. Logistic regression was used to assess associations of patient characteristics and outcomes. RESULTS: Of 4732 admissions, 1386 (29.3%) patients had AKI. Among those with AKI, 717 (51.7%) had stage 1 disease, 132 (9.5%) had stage 2 disease, 537 (38.7%) had stage 3 disease, and 237 (17.1%) required RRT initiation. In March, 536 of 1648 (32.5%) patients developed AKI compared with 15 of 87 (17.2%) in August (P < 0.001 for monthly trend), whereas RRT initiation was required in 6.9% and 0% of admissions in March and August, respectively. Mortality was higher with than without AKI (51.6% vs. 8.6%) and was 71.9% in individuals requiring RRT. However, most patients with AKI who survived hospitalization (77%) recovered to within 0.3 mg/dl of baseline creatinine. Among those surviving to discharge, 62% discontinued RRT. CONCLUSIONS: AKI impacts a high proportion of admitted patients with COVID-19 and is associated with high mortality, particularly when RRT is required. AKI incidence appears to be decreasing over time and kidney function frequently recovers in those who survive.
引用
- Charytan DM, Parnia S, Khatri M, et al. Decreasing Incidence of Acute Kidney Injury in Patients with COVID-19 Critical Illness in New York City. Kidney Int Rep. 2021. PMID: 33558853. doi:10.1016/j.ekir.2021.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。